اكتشف أفضل عيادات وتكاليف العلاج سرطان المريء في إيطاليا 2024

البروفيسور ريكاردو روساتي هو رئيس قسم جراحة الجهاز الهضمي (GI) في مستشفى أبحاث سان رافاييل. يقود أحد "المراكز الكبيرة الحجم" المعروفة لجراحة المريء في إيطاليا. يتمتع قسمه بخبرة واسعة في الجراحة المفتوحة والجراحة طفيفة التوغل للجهاز الهضمي ، وخاصة في مجال أمراض الأمعاء الأمامية والأمعاء الغليظة. يعالج قسم المستشفى الذي يرأسه البروفيسور روساتي ما يقرب من 2000 حالة جراحية سنويًا. خبرة في العمل منذ عام 2014 رئيس قسم جراحة الجهاز الهضمي في Ospedale San Raffaele في ميلانو 2009-2014 - مؤسس ومدير المركز الجامعي لأبحاث ورعاية أمراض المريء (CURE) في كلية الطب الدولية ، جامعة ميلانو 1996-2014 - رئيس قسم الجراحة العامة وجراحة الحد الأدنى من التدخل الجراحي في مستشفى أبحاث Humanitas 1985-1996 - جراح في قسم الجراحة العامة وجراحة الأورام في كلية الطب بجامعة ميلانو. تعليم 1980 - كلية الطب بجامعة ميلانو - إجازة في الطب العام 1985 - كلية الطب بجامعة ميلانو - تخصص في الجراحة العامة 1988 - كلية الطب بجامعة تورينو - تخصص في جراحة الصدر 1990 - شهادة البورد الوطني لرئاسة قسم الجراحة العامة. النشاط العلمي كتب أكثر من 300 مطبوعة. عضوية الكلية الأمريكية للجراحين الرابطة الإيطالية لجراحي المستشفيات الرابطة الأوروبية لجراحة المناظير الجمعية الدولية لأمراض المريء الجمعية الأوروبية لأمراض المريء الجمعية الإيطالية لجراحة الأورام الجمعية الإيطالية لجراحة المناظير والتقنيات الحديثة جمعية جراحة الجهاز الهضمى الرابطة الأوروبية للجراحة المجموعة الإيطالية لأبحاث سرطان المعدة.

Dr Braun's primary responsibilities include direct leadership and execution of complex surgeries, including gastric bypass, sleeve gastrectomy, and other advanced metabolic and bariatric procedures. He has developed solid experience in managing the different clinical challenges present in obese patients, providing them with personalized and optimized care to ensure positive long-term outcomes.His surgical practice is based on an in-depth methodology and a careful look at the latest technological innovations in the field of bariatric surgery. He has actively worked to implement advanced protocols and continually improve operational techniques, while maintaining the highest standards of patient safety and care.With over 2000 operations performed as a surgeon specializing in oncology, he has developed extensive experience and expertise in laparoscopic and robotic surgery applied to the care of cancer patients.As a primary operator, he has successfully conducted a wide range of laparoscopic and robotic surgeries for the treatment of oncological conditions, including gastrointestinal, urological, gynecological and other solid tumors. His surgical practice has focused on the application of advanced techniques, using cutting-edge laparoscopic instruments and robotic systems

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).